- Report
- April 2018
- 97 Pages
Global
From €14071EUR$16,000USD£12,265GBP
- Report
- June 2023
- 186 Pages
Global
From €4089EUR$4,650USD£3,565GBP
- Report
- November 2022
- 286 Pages
Global
From €2308EUR$2,625USD£2,012GBP
€4617EUR$5,250USD£4,024GBP
- Report
- September 2023
- 190 Pages
Global
From €2190EUR$2,490USD£1,909GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €3078EUR$3,500USD£2,683GBP
- Report
- October 2022
- 118 Pages
Global
From €3957EUR$4,500USD£3,450GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €3482EUR$3,960USD£3,036GBP
€4353EUR$4,950USD£3,794GBP
- Report
- January 2024
- 257 Pages
Global
From €4397EUR$5,000USD£3,833GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €3482EUR$3,960USD£3,036GBP
€4353EUR$4,950USD£3,794GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €3482EUR$3,960USD£3,036GBP
€4353EUR$4,950USD£3,794GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €3482EUR$3,960USD£3,036GBP
€4353EUR$4,950USD£3,794GBP
- Report
- March 2024
- 200 Pages
Global
From €3650EUR$4,150USD£3,181GBP
- Report
- January 2024
- 200 Pages
Global
From €3650EUR$4,150USD£3,181GBP
- Report
- November 2024
- 80 Pages
North America
From €3034EUR$3,450USD£2,645GBP
- Report
- December 2023
- 212 Pages
Global
€4393EUR$4,995USD£3,829GBP
- Report
- August 2024
- 150 Pages
Global
From €3386EUR$3,850USD£2,951GBP
€4265EUR$4,850USD£3,718GBP
- Report
- June 2022
- 242 Pages
Global
From €3166EUR$3,600USD£2,760GBP
- Report
- October 2025
- 95 Pages
Philippines
From €4265EUR$4,850USD£3,718GBP

Liver cancer is a type of cancer that originates in the liver, an organ located in the upper right side of the abdomen. It is the fifth most common cancer worldwide and the third leading cause of cancer-related death. Symptoms of liver cancer can include abdominal pain, jaundice, and weight loss. Treatment options for liver cancer include surgery, chemotherapy, radiation therapy, and targeted therapy.
The oncology market for liver cancer is highly competitive, with a range of treatments available. Pharmaceutical companies are investing in research and development to develop new treatments and improve existing ones. Additionally, the market is seeing an increase in the number of clinical trials for new treatments.
Companies in the liver cancer market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more